Sensorion SA (ALSEN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sensorion SA (ALSEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8258
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, acute vertigo, meniere’s disease, migraine-associated vertigo, benign paroxysmal positional vertigo, vestibular lesions and tinnitus, and ototoxicity. Sensorion offers clinical trial with SENS-111, a treatment against acute vertigo tested on volunteers to determine pharmacokinetics and tolerability; and SENS-401, a class drug to treat sudden sensori neural hearing loss. The company operates through researchers, clinicians and other partners, to develop its drugs. Sensorion is headquartered in Montpellier, France.

Sensorion SA (ALSEN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sensorion SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sensorion SA, Medical Devices Deals, 2012 to YTD 2018 9
Sensorion SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sensorion SA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Sensorion Raises USD4.6 Million in Venture Financing 11
Partnerships 12
Sensorion Enters into Partnership Agreement with Cochlear 12
Palau Pharma Enters Into Agreement With Sensorion To Develop UR-63325 13
Equity Offering 14
Sensorion Raises USD10.2 Million in Private Placement of Shares 14
Sensorion Raises USD1.8 Million in Private Placement of Shares 16
Sensorion Raises USD8.7 Million in Private Placement of Shares 17
Sensorion Raises USD9 Million in IPO 18
Sensorion SA – Key Competitors 19
Sensorion SA – Key Employees 20
Sensorion SA – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Oct 18, 2018: Sensorion reports pipeline update and first-half-year 2018 results; re-design of SENS-111 study 22
Apr 12, 2018: Sensorion reports full year 2017 results 25
Oct 18, 2017: Sensorion Reports 2017 First-Half Results 27
Mar 14, 2017: Sensorion Reports Full Year 2016 Results in Line with Status of Clinical Development 30
Corporate Communications 32
May 22, 2018: Sensorion Appoints Professor Christine Petit, MD, PhD as Chair of its Scientific Advisory Board 32
Jun 08, 2017: Sensorion Announces Results from 2017 Annual General Meeting 33
Apr 13, 2017: SENSORION: Intensification of the Company’s International Development with the Appointment of a New CEO 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Sensorion SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sensorion SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sensorion SA, Deals By Therapy Area, 2012 to YTD 2018 8
Sensorion SA, Medical Devices Deals, 2012 to YTD 2018 9
Sensorion SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sensorion Raises USD4.6 Million in Venture Financing 11
Sensorion Enters into Partnership Agreement with Cochlear 12
Palau Pharma Enters Into Agreement With Sensorion To Develop UR-63325 13
Sensorion Raises USD10.2 Million in Private Placement of Shares 14
Sensorion Raises USD1.8 Million in Private Placement of Shares 16
Sensorion Raises USD8.7 Million in Private Placement of Shares 17
Sensorion Raises USD9 Million in IPO 18
Sensorion SA, Key Competitors 19
Sensorion SA, Key Employees 20

List of Figures
Sensorion SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sensorion SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sensorion SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sensorion SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sensorion SA (ALSEN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sangam (India) Ltd.:企業の戦略・SWOT・財務分析
    Sangam (India) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sangam (India) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Inretail Peru Corp.:企業の戦略的SWOT分析
    Inretail Peru Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • The Independent Order of Foresters:企業の戦略的SWOT分析
    The Independent Order of Foresters - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Euler Hermes SA:戦略・SWOT・企業財務分析
    Euler Hermes SA - Strategy, SWOT and Corporate Finance Report Summary Euler Hermes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ExxonMobil Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary ExxonMobil Pipeline Co (EMPCO) a subsidiary of Exxon Mobil Corporation is an oil and gas company that offers petroleum products transportation solutions. The company transports crude oil, refined products, liquefied petroleum gases, natural gas liquids and chemical feed-stocks. Its distribut …
  • EnBW Energie Baden-Wurttemberg AG:企業の発電所・SWOT分析2018
    EnBW Energie Baden-Wurttemberg AG - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Zeria Pharmaceutical Co Ltd (4559):企業の財務・戦略的SWOT分析
    Summary Zeria Pharmaceutical Co Ltd (Zeria), formerly Zeria Yakusho Kenkyusho Co Ltd is a pharmaceutical company that manufactures pharmaceutical and non-pharmaceuticals, veterinary pharmaceuticals, industrial chemicals and reagents. The company imports and exports healthcare products such as cosmet …
  • Yamaha Corporation (7951):企業の財務・戦略的SWOT分析
    Yamaha Corporation (7951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fresenius Kabi USA LLC-製薬・医療分野:企業M&A・提携分析
    Summary Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically il …
  • Jubilee Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Z Energy Ltd:企業の戦略・SWOT・財務分析
    Z Energy Ltd - Strategy, SWOT and Corporate Finance Report Summary Z Energy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Hague and London Oil PLC (HNL):企業の財務・戦略的SWOT分析
    Summary Hague and London Oil PLC (HALO), formerly Wessex Exploration plc, is an oil and gas exploration company that develops resource properties. The company acquires, explores, produces, and develops oil and gas resource properties across the UK. Its projects comprise assets in the Philippines, Gu …
  • Volta River Authority-エネルギー分野:企業M&A・提携分析
    Summary Volta River Authority (VRA) is a state-owned energy utility that generates, transmits, and distributes electricity. The authority produces power from solar, hydro, light crude oil, distillate fuel oil, and heavy fuel oil sources. It procures energy from Takoradi International Company Ltd; an …
  • Bone Biologics Corp (BBLG):製薬・医療:M&Aディール及び事業提携情報
    Summary Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. The company develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also …
  • St. Jude Medical, Inc.:企業のM&A・事業提携・投資動向
    St. Jude Medical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's St. Jude Medical, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Esperion Therapeutics Inc (ESPR):企業の財務・戦略的SWOT分析
    Summary Esperion Therapeutics Inc (Esperion), is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). Its …
  • Realty Income Corporation:企業のM&A・事業提携・投資動向
    Realty Income Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Realty Income Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Imperial Brands Plc:企業の戦略・SWOT・財務情報
    Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report Summary Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NSK Ltd.:企業の戦略・SWOT・財務分析
    NSK Ltd. - Strategy, SWOT and Corporate Finance Report Summary NSK Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Cytune Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Cytune Pharma SAS (Cytune) is a health care product developer that develops immunotherapeutic agents for the treatment of cancer and infectious diseases. The company’s product portfolio includes recombinant proteins and monoclonal antibodies. Its CYP0150 is a recombinant protein, which decre …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆